Brief: Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
28/10/2025 12:26
Oct 28 (Reuters) - Terumo Corp 4543.T: ORCHESTRA BIOMED AND TERUMO ENTER INTO NEW $30 MILLION VIRTUE SAB STRATEGIC AGREEMENTS ORCHESTRA BIOMED - TERUMO TO PAY $30 MILLION TO ORCHESTRA BIOMED ORCHESTRA BIOMED HOLDINGS: RETAINS ALL DEVELOPMENT AND DISTRIBUTION RIGHTS TO VIRTUE SAB IN ALL INDICATIONS Source text: ID:nGNXWZhTP Further company coverage: 4543.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens